Skip Navigation



Carcinogenesis Advance Access published online on August 8, 2007

Carcinogenesis, doi:10.1093/carcin/bgm175
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrowOA All Versions of this Article:
28/9/2013    most recent
bgm175v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Yamada, H.
Right arrow Articles by Sugimura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, H.
Right arrow Articles by Sugimura, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Identification and characterization of a novel germline p53 mutation in familial gastric cancer in the Japanese population

Hidetaka Yamada1,2, Kazuya Shinmura1, Koji Okudela1, Masanori Goto1, Masaya Suzuki1, Ken Kuriki3, Toshihiro Tsuneyoshi2 and Haruhiko Sugimura1,5

1 First Department of Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan
2 Department of Materials and Life Science, Shizuoka Institute of Science and Technology, 2200-2 Toyosawa, Fukuroi, Shizuoka 437-8555, Japan
3 Department of Pathology, Yaizu Municipal Hospital, 1000 Dobara, Yaizu 425-8505, Japan

5 To whom requests for reprints should be addressed, at First Department of Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan Phone: 53-435-2220; Fax: 53-435-2225; E-mail: hsugimur{at}hama-med.ac.jp

Germline mutations of the p53 gene are known to cause Li-Fraumeni syndrome, and a germline p53 mutation has recently been reported in a small subset of familial gastric cancer (FGC) in Europe and Korea. Although the incidence of gastric cancer is very high in Japan and familial clustering is not uncommon, there has been little information on the genetic factors of FGC. Therefore, to determine the role of germline p53 mutations in FGC in the Japanese population in this study we used sequencing analysis to examine 80 individuals from 35 Japanese FGC families without germline CDH1 mutations for germline p53 mutations. One missense (c.91G>A: p.Val31Ile) and two intronic germline mutations were found, and transcriptional activity of the Ile31 mutant on p53 responsive genes was examined to determine the functional effect of the novel p.Val31Ile germline mutation. A luciferase reporter assay showed that the transcriptional activity of p21 (CDKN1A) and MDM2 promoters but not of the BAX promoter was significantly lower in the Ile31-type p53 than in the wild-type p53. Next, doxycycline-regulated p53-inducible H1299 cell lines were established by applying a retrovirus-mediated gene transfer system to a p53-null human H1299 cell line. Under similar p53 expression conditions shown by Western blot and immunofluorescence analyses, a cell proliferation assay showed that the Ile31-type p53 had significantly lower cell proliferation suppressing activity than wild-type p53. These results suggest that Ile31-type p53 may be partly involved in FGC because of its low transcriptional activity and low cell proliferation suppressing activity.

Received May 31, 2007; revised July 23, 2007; accepted July 23, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
M Iwaizumi, K Shinmura, H Mori, H Yamada, M Suzuki, Y Kitayama, H Igarashi, T Nakamura, H Suzuki, Y Watanabe, et al.
Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer
Gut, February 1, 2009; 58(2): 249 - 260.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.